ACT-129968

DRUG2 trials

Sponsors

Idorsia Pharmaceuticals Ltd.

Conditions

Seasonal Allergic Rhinitis

Phase 2

Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis

CompletedNCT01241214

Idorsia Pharmaceuticals Ltd.Seasonal Allergic Rhinitis

Start: 2010-11-30End: 2011-02-28Updated: 2019-05-15

Phase 3

Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis

CompletedNCT01484119

Idorsia Pharmaceuticals Ltd.Seasonal Allergic Rhinitis

Start: 2011-12-31End: 2012-03-31Updated: 2018-09-28

Related Papers

Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies.

2017-04-0422 citations